nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0827	0.152	CbGbCtD
Clonidine—CYP1A2—Leflunomide—systemic scleroderma	0.0789	0.145	CbGbCtD
Clonidine—ABCB1—Lisinopril—systemic scleroderma	0.0723	0.133	CbGbCtD
Clonidine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0655	0.12	CbGbCtD
Clonidine—ABCB1—Captopril—systemic scleroderma	0.0542	0.0995	CbGbCtD
Clonidine—CYP2D6—Captopril—systemic scleroderma	0.051	0.0937	CbGbCtD
Clonidine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0426	0.0783	CbGbCtD
Clonidine—ABCB1—Prednisone—systemic scleroderma	0.0341	0.0626	CbGbCtD
Clonidine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0255	0.0469	CbGbCtD
Clonidine—CYP3A4—Prednisone—systemic scleroderma	0.0204	0.0375	CbGbCtD
Clonidine—ABCB1—Methotrexate—systemic scleroderma	0.0171	0.0314	CbGbCtD
Clonidine—Pruritus—Captopril—systemic scleroderma	0.000402	0.000881	CcSEcCtD
Clonidine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000401	0.00088	CcSEcCtD
Clonidine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000879	CcSEcCtD
Clonidine—Constipation—Leflunomide—systemic scleroderma	0.0004	0.000878	CcSEcCtD
Clonidine—Pain—Leflunomide—systemic scleroderma	0.0004	0.000878	CcSEcCtD
Clonidine—Infection—Lisinopril—systemic scleroderma	0.000399	0.000877	CcSEcCtD
Clonidine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000398	0.000873	CcSEcCtD
Clonidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000397	0.000871	CcSEcCtD
Clonidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00087	CcSEcCtD
Clonidine—Shock—Lisinopril—systemic scleroderma	0.000395	0.000868	CcSEcCtD
Clonidine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000394	0.000866	CcSEcCtD
Clonidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000394	0.000864	CcSEcCtD
Clonidine—Tachycardia—Lisinopril—systemic scleroderma	0.000392	0.000861	CcSEcCtD
Clonidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000392	0.00086	CcSEcCtD
Clonidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000392	0.00086	CcSEcCtD
Clonidine—Skin disorder—Lisinopril—systemic scleroderma	0.00039	0.000857	CcSEcCtD
Clonidine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000854	CcSEcCtD
Clonidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000389	0.000853	CcSEcCtD
Clonidine—Diarrhoea—Captopril—systemic scleroderma	0.000388	0.000852	CcSEcCtD
Clonidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000388	0.000852	CcSEcCtD
Clonidine—Irritability—Methotrexate—systemic scleroderma	0.000387	0.00085	CcSEcCtD
Clonidine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000387	0.000849	CcSEcCtD
Clonidine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000387	0.000849	CcSEcCtD
Clonidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000385	0.000846	CcSEcCtD
Clonidine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000385	0.000846	CcSEcCtD
Clonidine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000385	0.000845	CcSEcCtD
Clonidine—Nausea—Mometasone—systemic scleroderma	0.000384	0.000843	CcSEcCtD
Clonidine—Anorexia—Lisinopril—systemic scleroderma	0.000383	0.000841	CcSEcCtD
Clonidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000382	0.00084	CcSEcCtD
Clonidine—Weight increased—Prednisone—systemic scleroderma	0.000382	0.000839	CcSEcCtD
Clonidine—Pain—Mycophenolic acid—systemic scleroderma	0.000382	0.000838	CcSEcCtD
Clonidine—Constipation—Mycophenolic acid—systemic scleroderma	0.000382	0.000838	CcSEcCtD
Clonidine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000837	CcSEcCtD
Clonidine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000379	0.000833	CcSEcCtD
Clonidine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000827	CcSEcCtD
Clonidine—Hypotension—Lisinopril—systemic scleroderma	0.000376	0.000824	CcSEcCtD
Clonidine—Dizziness—Captopril—systemic scleroderma	0.000375	0.000824	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000375	0.000823	CcSEcCtD
Clonidine—Depression—Prednisone—systemic scleroderma	0.000373	0.000819	CcSEcCtD
Clonidine—Urticaria—Leflunomide—systemic scleroderma	0.000372	0.000816	CcSEcCtD
Clonidine—Abdominal pain—Leflunomide—systemic scleroderma	0.00037	0.000812	CcSEcCtD
Clonidine—Body temperature increased—Leflunomide—systemic scleroderma	0.00037	0.000812	CcSEcCtD
Clonidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000368	0.000807	CcSEcCtD
Clonidine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000806	CcSEcCtD
Clonidine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000806	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—systemic scleroderma	0.000367	0.000805	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000366	0.000804	CcSEcCtD
Clonidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000804	CcSEcCtD
Clonidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000365	0.000801	CcSEcCtD
Clonidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000365	0.000801	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000801	CcSEcCtD
Clonidine—Insomnia—Lisinopril—systemic scleroderma	0.000364	0.000798	CcSEcCtD
Clonidine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000363	0.000797	CcSEcCtD
Clonidine—Paraesthesia—Lisinopril—systemic scleroderma	0.000361	0.000792	CcSEcCtD
Clonidine—Vomiting—Captopril—systemic scleroderma	0.000361	0.000792	CcSEcCtD
Clonidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000789	CcSEcCtD
Clonidine—Dyspnoea—Lisinopril—systemic scleroderma	0.000358	0.000787	CcSEcCtD
Clonidine—Rash—Captopril—systemic scleroderma	0.000358	0.000786	CcSEcCtD
Clonidine—Dermatitis—Captopril—systemic scleroderma	0.000357	0.000785	CcSEcCtD
Clonidine—Somnolence—Lisinopril—systemic scleroderma	0.000357	0.000784	CcSEcCtD
Clonidine—Headache—Captopril—systemic scleroderma	0.000356	0.00078	CcSEcCtD
Clonidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000355	0.000779	CcSEcCtD
Clonidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000353	0.000774	CcSEcCtD
Clonidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000353	0.000774	CcSEcCtD
Clonidine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000773	CcSEcCtD
Clonidine—Asthma—Methotrexate—systemic scleroderma	0.000351	0.00077	CcSEcCtD
Clonidine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000768	CcSEcCtD
Clonidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000349	0.000767	CcSEcCtD
Clonidine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000347	0.000762	CcSEcCtD
Clonidine—Fatigue—Lisinopril—systemic scleroderma	0.000347	0.000761	CcSEcCtD
Clonidine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000761	CcSEcCtD
Clonidine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000758	CcSEcCtD
Clonidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000757	CcSEcCtD
Clonidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000345	0.000757	CcSEcCtD
Clonidine—Pain—Lisinopril—systemic scleroderma	0.000344	0.000755	CcSEcCtD
Clonidine—Constipation—Lisinopril—systemic scleroderma	0.000344	0.000755	CcSEcCtD
Clonidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000754	CcSEcCtD
Clonidine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000751	CcSEcCtD
Clonidine—Bradycardia—Prednisone—systemic scleroderma	0.000342	0.000751	CcSEcCtD
Clonidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00034	0.000747	CcSEcCtD
Clonidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000339	0.000744	CcSEcCtD
Clonidine—Nausea—Captopril—systemic scleroderma	0.000337	0.00074	CcSEcCtD
Clonidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000737	CcSEcCtD
Clonidine—Asthenia—Leflunomide—systemic scleroderma	0.000336	0.000737	CcSEcCtD
Clonidine—Hallucination—Prednisone—systemic scleroderma	0.000334	0.000734	CcSEcCtD
Clonidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000331	0.000727	CcSEcCtD
Clonidine—Pruritus—Leflunomide—systemic scleroderma	0.000331	0.000726	CcSEcCtD
Clonidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000722	CcSEcCtD
Clonidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000329	0.000721	CcSEcCtD
Clonidine—Dysuria—Methotrexate—systemic scleroderma	0.000328	0.00072	CcSEcCtD
Clonidine—Dizziness—Azathioprine—systemic scleroderma	0.000328	0.000719	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000326	0.000716	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000323	0.000709	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000704	CcSEcCtD
Clonidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00032	0.000703	CcSEcCtD
Clonidine—Diarrhoea—Leflunomide—systemic scleroderma	0.00032	0.000703	CcSEcCtD
Clonidine—Urticaria—Lisinopril—systemic scleroderma	0.000319	0.000701	CcSEcCtD
Clonidine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000699	CcSEcCtD
Clonidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000318	0.000697	CcSEcCtD
Clonidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000318	0.000697	CcSEcCtD
Clonidine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000694	CcSEcCtD
Clonidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000316	0.000693	CcSEcCtD
Clonidine—Vomiting—Azathioprine—systemic scleroderma	0.000315	0.000691	CcSEcCtD
Clonidine—Eye disorder—Prednisone—systemic scleroderma	0.000314	0.000689	CcSEcCtD
Clonidine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000689	CcSEcCtD
Clonidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000687	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—systemic scleroderma	0.000313	0.000687	CcSEcCtD
Clonidine—Rash—Azathioprine—systemic scleroderma	0.000312	0.000686	CcSEcCtD
Clonidine—Dermatitis—Azathioprine—systemic scleroderma	0.000312	0.000685	CcSEcCtD
Clonidine—Depression—Methotrexate—systemic scleroderma	0.000312	0.000685	CcSEcCtD
Clonidine—Headache—Azathioprine—systemic scleroderma	0.00031	0.000681	CcSEcCtD
Clonidine—Dizziness—Leflunomide—systemic scleroderma	0.000309	0.000679	CcSEcCtD
Clonidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000672	CcSEcCtD
Clonidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000305	0.00067	CcSEcCtD
Clonidine—Angiopathy—Prednisone—systemic scleroderma	0.000305	0.000669	CcSEcCtD
Clonidine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000667	CcSEcCtD
Clonidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000661	CcSEcCtD
Clonidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000661	CcSEcCtD
Clonidine—Arrhythmia—Prednisone—systemic scleroderma	0.0003	0.000659	CcSEcCtD
Clonidine—Sweating—Methotrexate—systemic scleroderma	0.0003	0.000658	CcSEcCtD
Clonidine—Vomiting—Leflunomide—systemic scleroderma	0.000297	0.000653	CcSEcCtD
Clonidine—Alopecia—Prednisone—systemic scleroderma	0.000297	0.000652	CcSEcCtD
Clonidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000296	0.00065	CcSEcCtD
Clonidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000295	0.000648	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—systemic scleroderma	0.000295	0.000648	CcSEcCtD
Clonidine—Rash—Leflunomide—systemic scleroderma	0.000295	0.000647	CcSEcCtD
Clonidine—Dermatitis—Leflunomide—systemic scleroderma	0.000295	0.000647	CcSEcCtD
Clonidine—Mental disorder—Prednisone—systemic scleroderma	0.000294	0.000646	CcSEcCtD
Clonidine—Nausea—Azathioprine—systemic scleroderma	0.000294	0.000646	CcSEcCtD
Clonidine—Headache—Leflunomide—systemic scleroderma	0.000293	0.000643	CcSEcCtD
Clonidine—Erythema—Prednisone—systemic scleroderma	0.000292	0.000642	CcSEcCtD
Clonidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000637	CcSEcCtD
Clonidine—Asthenia—Lisinopril—systemic scleroderma	0.000288	0.000633	CcSEcCtD
Clonidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000632	CcSEcCtD
Clonidine—Pruritus—Lisinopril—systemic scleroderma	0.000284	0.000624	CcSEcCtD
Clonidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000284	0.000623	CcSEcCtD
Clonidine—Rash—Mycophenolic acid—systemic scleroderma	0.000281	0.000618	CcSEcCtD
Clonidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000281	0.000617	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—systemic scleroderma	0.000281	0.000616	CcSEcCtD
Clonidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000614	CcSEcCtD
Clonidine—Headache—Mycophenolic acid—systemic scleroderma	0.00028	0.000614	CcSEcCtD
Clonidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000611	CcSEcCtD
Clonidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000611	CcSEcCtD
Clonidine—Nausea—Leflunomide—systemic scleroderma	0.000278	0.00061	CcSEcCtD
Clonidine—Vision blurred—Prednisone—systemic scleroderma	0.000276	0.000605	CcSEcCtD
Clonidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000275	0.000604	CcSEcCtD
Clonidine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000271	0.000596	CcSEcCtD
Clonidine—Agitation—Prednisone—systemic scleroderma	0.000269	0.00059	CcSEcCtD
Clonidine—Angioedema—Prednisone—systemic scleroderma	0.000267	0.000587	CcSEcCtD
Clonidine—Dizziness—Lisinopril—systemic scleroderma	0.000266	0.000583	CcSEcCtD
Clonidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000265	0.000582	CcSEcCtD
Clonidine—Malaise—Prednisone—systemic scleroderma	0.000264	0.000579	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—systemic scleroderma	0.000262	0.000576	CcSEcCtD
Clonidine—Syncope—Prednisone—systemic scleroderma	0.000262	0.000576	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—systemic scleroderma	0.000262	0.000575	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000261	0.000572	CcSEcCtD
Clonidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00057	CcSEcCtD
Clonidine—Loss of consciousness—Prednisone—systemic scleroderma	0.000257	0.000564	CcSEcCtD
Clonidine—Vomiting—Lisinopril—systemic scleroderma	0.000256	0.000561	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—systemic scleroderma	0.000255	0.000559	CcSEcCtD
Clonidine—Rash—Lisinopril—systemic scleroderma	0.000253	0.000556	CcSEcCtD
Clonidine—Dermatitis—Lisinopril—systemic scleroderma	0.000253	0.000556	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000253	0.000556	CcSEcCtD
Clonidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000555	CcSEcCtD
Clonidine—Headache—Lisinopril—systemic scleroderma	0.000252	0.000553	CcSEcCtD
Clonidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000547	CcSEcCtD
Clonidine—Arthralgia—Prednisone—systemic scleroderma	0.000249	0.000547	CcSEcCtD
Clonidine—Anxiety—Prednisone—systemic scleroderma	0.000248	0.000545	CcSEcCtD
Clonidine—Alopecia—Methotrexate—systemic scleroderma	0.000248	0.000545	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000247	0.000543	CcSEcCtD
Clonidine—Discomfort—Prednisone—systemic scleroderma	0.000246	0.00054	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—systemic scleroderma	0.000246	0.00054	CcSEcCtD
Clonidine—Erythema—Methotrexate—systemic scleroderma	0.000244	0.000537	CcSEcCtD
Clonidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000529	CcSEcCtD
Clonidine—Nausea—Lisinopril—systemic scleroderma	0.000239	0.000524	CcSEcCtD
Clonidine—Oedema—Prednisone—systemic scleroderma	0.000239	0.000524	CcSEcCtD
Clonidine—Infection—Prednisone—systemic scleroderma	0.000237	0.000521	CcSEcCtD
Clonidine—Shock—Prednisone—systemic scleroderma	0.000235	0.000516	CcSEcCtD
Clonidine—Nervous system disorder—Prednisone—systemic scleroderma	0.000234	0.000514	CcSEcCtD
Clonidine—Tachycardia—Prednisone—systemic scleroderma	0.000233	0.000511	CcSEcCtD
Clonidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000511	CcSEcCtD
Clonidine—Skin disorder—Prednisone—systemic scleroderma	0.000232	0.000509	CcSEcCtD
Clonidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000231	0.000507	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—systemic scleroderma	0.00023	0.000506	CcSEcCtD
Clonidine—Anorexia—Prednisone—systemic scleroderma	0.000228	0.000499	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000227	0.000498	CcSEcCtD
Clonidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000492	CcSEcCtD
Clonidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000487	CcSEcCtD
Clonidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000487	CcSEcCtD
Clonidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000484	CcSEcCtD
Clonidine—Malaise—Methotrexate—systemic scleroderma	0.00022	0.000484	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000217	0.000477	CcSEcCtD
Clonidine—Insomnia—Prednisone—systemic scleroderma	0.000216	0.000474	CcSEcCtD
Clonidine—Paraesthesia—Prednisone—systemic scleroderma	0.000214	0.000471	CcSEcCtD
Clonidine—Cough—Methotrexate—systemic scleroderma	0.000213	0.000468	CcSEcCtD
Clonidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000459	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—systemic scleroderma	0.000208	0.000457	CcSEcCtD
Clonidine—Chest pain—Methotrexate—systemic scleroderma	0.000208	0.000457	CcSEcCtD
Clonidine—Decreased appetite—Prednisone—systemic scleroderma	0.000207	0.000456	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000207	0.000454	CcSEcCtD
Clonidine—Fatigue—Prednisone—systemic scleroderma	0.000206	0.000452	CcSEcCtD
Clonidine—Discomfort—Methotrexate—systemic scleroderma	0.000206	0.000451	CcSEcCtD
Clonidine—Constipation—Prednisone—systemic scleroderma	0.000204	0.000448	CcSEcCtD
Clonidine—Confusional state—Methotrexate—systemic scleroderma	0.000201	0.000442	CcSEcCtD
Clonidine—Infection—Methotrexate—systemic scleroderma	0.000198	0.000435	CcSEcCtD
Clonidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000197	0.000432	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000196	0.000429	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000195	0.000429	CcSEcCtD
Clonidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000195	0.000428	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—systemic scleroderma	0.000194	0.000425	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000193	0.000423	CcSEcCtD
Clonidine—Anorexia—Methotrexate—systemic scleroderma	0.00019	0.000417	CcSEcCtD
Clonidine—Urticaria—Prednisone—systemic scleroderma	0.00019	0.000416	CcSEcCtD
Clonidine—Body temperature increased—Prednisone—systemic scleroderma	0.000189	0.000414	CcSEcCtD
Clonidine—Abdominal pain—Prednisone—systemic scleroderma	0.000189	0.000414	CcSEcCtD
Clonidine—Hypotension—Methotrexate—systemic scleroderma	0.000186	0.000409	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000182	0.000399	CcSEcCtD
Clonidine—Insomnia—Methotrexate—systemic scleroderma	0.00018	0.000396	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—systemic scleroderma	0.000179	0.000393	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—systemic scleroderma	0.000178	0.00039	CcSEcCtD
Clonidine—Somnolence—Methotrexate—systemic scleroderma	0.000177	0.000389	CcSEcCtD
Clonidine—Hypersensitivity—Prednisone—systemic scleroderma	0.000176	0.000386	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000173	0.000381	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000172	0.000378	CcSEcCtD
Clonidine—Fatigue—Methotrexate—systemic scleroderma	0.000172	0.000378	CcSEcCtD
Clonidine—Asthenia—Prednisone—systemic scleroderma	0.000171	0.000376	CcSEcCtD
Clonidine—Pain—Methotrexate—systemic scleroderma	0.000171	0.000374	CcSEcCtD
Clonidine—Pruritus—Prednisone—systemic scleroderma	0.000169	0.000371	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000164	0.000361	CcSEcCtD
Clonidine—Diarrhoea—Prednisone—systemic scleroderma	0.000163	0.000359	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000163	0.000358	CcSEcCtD
Clonidine—Urticaria—Methotrexate—systemic scleroderma	0.000158	0.000348	CcSEcCtD
Clonidine—Dizziness—Prednisone—systemic scleroderma	0.000158	0.000347	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000158	0.000346	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000158	0.000346	CcSEcCtD
Clonidine—Vomiting—Prednisone—systemic scleroderma	0.000152	0.000333	CcSEcCtD
Clonidine—Rash—Prednisone—systemic scleroderma	0.000151	0.00033	CcSEcCtD
Clonidine—Dermatitis—Prednisone—systemic scleroderma	0.00015	0.00033	CcSEcCtD
Clonidine—Headache—Prednisone—systemic scleroderma	0.00015	0.000328	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000147	0.000323	CcSEcCtD
Clonidine—Asthenia—Methotrexate—systemic scleroderma	0.000143	0.000314	CcSEcCtD
Clonidine—Nausea—Prednisone—systemic scleroderma	0.000142	0.000311	CcSEcCtD
Clonidine—Pruritus—Methotrexate—systemic scleroderma	0.000141	0.00031	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000136	0.0003	CcSEcCtD
Clonidine—Dizziness—Methotrexate—systemic scleroderma	0.000132	0.00029	CcSEcCtD
Clonidine—Vomiting—Methotrexate—systemic scleroderma	0.000127	0.000278	CcSEcCtD
Clonidine—Rash—Methotrexate—systemic scleroderma	0.000126	0.000276	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—systemic scleroderma	0.000126	0.000276	CcSEcCtD
Clonidine—Headache—Methotrexate—systemic scleroderma	0.000125	0.000274	CcSEcCtD
Clonidine—Nausea—Methotrexate—systemic scleroderma	0.000118	0.00026	CcSEcCtD
